Misonix, Inc. (NASDAQ:MSON)’s stock price rose 17.1% during mid-day trading on Friday following a better than expected earnings announcement. The company traded as high as $20.51 and last traded at $19.62, approximately 103,666 shares traded hands during mid-day trading. An increase of 136% from the average daily volume of 43,956 shares. The stock had previously closed at $16.75.
The medical equipment provider reported $0.17 EPS for the quarter, topping the consensus estimate of ($0.17) by $0.34. Misonix had a negative return on equity of 25.99% and a negative net margin of 19.01%. The business had revenue of $11.15 million during the quarter.
MSON has been the subject of several analyst reports. BTIG Research restated a “buy” rating and issued a $27.00 target price on shares of Misonix in a research note on Thursday, August 15th. Canaccord Genuity restated a “buy” rating and issued a $30.00 target price (up previously from $24.00) on shares of Misonix in a research note on Thursday, August 15th. Finally, ValuEngine downgraded Misonix from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. One research analyst has rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $28.50.
The stock’s 50-day simple moving average is $18.09 and its 200 day simple moving average is $20.76.
About Misonix (NASDAQ:MSON)
Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells.
Further Reading: What is the role of the G-20?
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.